Home » Newsletters » BioWorld MedTech

BioWorld MedTech

May 8, 2014

View Archived Issues

The MDD Interview, Part I: NICE Insight: Campbell says evidence needs to drive med-tech evaluations

Were Expectations Inflated?: Analysts find Mindray quarterly results to be worse than expected

Financings: EndroGastric Solutions gets $30M in private funding for GERD treatment

Report from Europe: Smart Smartt ePatch making chemistry run like a Swiss clock

World in Review: Elekta to provide Canadian center with linear software

Deals: Kimberly-Clark in plan to spin out healthcare business, Halyard Health

Agreements/contracts: Sectra secures an order with Cleveland's University Hospitals

Briefly noted

People

Products

MDD's Orthopedic Extra

SEMDA 2014: SEMDA pushes theme of thriving in new healthcare landscape

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 2, 2025.
CMS vows to put more emphasis on MA plans’ prior authorization
BioWorld MedTech
Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
Filling the NIH funding gap to protect biopharma research
BioWorld
The Trump administration’s broad slash to university research budgets raises pertinent questions over impacts to the biopharma ecosystem, specifically how a...